282 related articles for article (PubMed ID: 10736491)
21. Overexpression of p53 in transitional cell carcinoma of the renal pelvis and ureter. Relation to tumor proliferation and survival.
Rey A; Lara PC; Redondo E; Valdés E; Apolinario R
Cancer; 1997 Jun; 79(11):2178-85. PubMed ID: 9179065
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW
Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925
[TBL] [Abstract][Full Text] [Related]
23. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
[TBL] [Abstract][Full Text] [Related]
24. Percentage of high-grade carcinoma as a prognostic indicator in patients with renal cell carcinoma.
Serrano MF; Katz M; Yan Y; Kibel AS; Humphrey PA
Cancer; 2008 Aug; 113(3):477-83. PubMed ID: 18484589
[TBL] [Abstract][Full Text] [Related]
25. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.
Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K; Kosma VM
Br J Cancer; 1999 Aug; 80(12):2001-7. PubMed ID: 10471053
[TBL] [Abstract][Full Text] [Related]
26. p53 expression in correlation to clinical outcome in patients with renal cell carcinoma.
Ljungberg B; Bozoky B; Kovacs G; Stattin P; Farrelly E; Nylander K; Landberg G
Scand J Urol Nephrol; 2001 Feb; 35(1):15-20. PubMed ID: 11291681
[TBL] [Abstract][Full Text] [Related]
27. Association of immunohistochemical staining for p53 with metastatic progression and poor survival in patients with renal cell carcinoma.
Uhlman DL; Nguyen PL; Manivel JC; Aeppli D; Resnick JM; Fraley EE; Zhang G; Niehans GA
J Natl Cancer Inst; 1994 Oct; 86(19):1470-5. PubMed ID: 8089867
[TBL] [Abstract][Full Text] [Related]
28. Growth fractions of human renal cell carcinoma defined by monoclonal antibody Ki-67. Predictive values for prognosis.
Yuba H; Okamura K; Ono Y; Ohshima S
Int J Urol; 2001 Nov; 8(11):609-14. PubMed ID: 11903687
[TBL] [Abstract][Full Text] [Related]
29. Incidence of apoptosis, cell proliferation and P53 expression in renal cell carcinomas.
Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW
Anticancer Res; 1997; 17(2A):1155-62. PubMed ID: 9137464
[TBL] [Abstract][Full Text] [Related]
30. Squamous cell carcinoma of the oropharynx: Ki-67 and p53 can identify patients at high risk for local recurrence after surgery and postoperative radiotherapy.
Grabenbauer GG; Mühlfriedel C; Rödel F; Niedobitek G; Hornung J; Rödel C; Martus P; Iro H; Kirchner T; Steininger H; Sauer R; Weidenbecher M; Distel L
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1041-50. PubMed ID: 11072161
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of MCM2 immunoreactivity in stage T1 transitional cell carcinoma of the bladder.
Krüger S; Thorns C; Stöcker W; Müller-Kunert E; Böhle A; Feller AC
Eur Urol; 2003 Feb; 43(2):138-45. PubMed ID: 12565771
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
[TBL] [Abstract][Full Text] [Related]
33. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.
Tsui KH; Shvarts O; Smith RB; Figlin RA; deKernion JB; Belldegrun A
J Urol; 2000 Apr; 163(4):1090-5; quiz 1295. PubMed ID: 10737472
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors in patients with renal cell carcinoma: retrospective analysis of 675 cases.
Ficarra V; Righetti R; Pilloni S; D'amico A; Maffei N; Novella G; Zanolla L; Malossini G; Mobilio G
Eur Urol; 2002 Feb; 41(2):190-8. PubMed ID: 12074408
[TBL] [Abstract][Full Text] [Related]
35. MCM - 2 and Ki - 67 as proliferation markers in renal cell carcinoma: A quantitative and semi - quantitative analysis.
Mehdi MZ; Nagi AH; Naseem N
Int Braz J Urol; 2016; 42(6):1121-1128. PubMed ID: 27532114
[TBL] [Abstract][Full Text] [Related]
36. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
[TBL] [Abstract][Full Text] [Related]
37. [Survival analysis for localized renal cell carcinoma. Prognostic value of 1997 TNM classification].
García Torrelles M; Sánchez Sanchís M; Beltrán Armada JR; Bautista Rentero D; Vidal Moreno J; Sanjuán de Laorden C
Actas Urol Esp; 2006; 30(7):655-60. PubMed ID: 17058609
[TBL] [Abstract][Full Text] [Related]
38. Selected immunohistochemical features of conventional renal cell carcinomas coexpressing P53 and MDM2.
Hejnold M; Dyduch G; Białas M; Demczuk S; Ryś J; Chłosta P; Szopiński T; Okoń K
Pol J Pathol; 2014 Jun; 65(2):113-9. PubMed ID: 25119170
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of extensive necrosis in renal cell carcinoma.
Collins J; Epstein JI
Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
[TBL] [Abstract][Full Text] [Related]
40. Significance of conventional and new prognostic factors for locally confined renal cell carcinoma.
Hofmockel G; Tsatalpas P; Müller H; Dämmrich J; Poot M; Maurer-Schultze B; Müller-Hermelink HK; Frohmüller HG; Bassukas ID
Cancer; 1995 Jul; 76(2):296-306. PubMed ID: 8625106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
